JP Morgan Chase
WGS icon

JP Morgan Chase’s GeneDx Holdings WGS Stock Holding History

JP Morgan Chase’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,000
Closed -$974K – 7693
2025
Q1 		$974K Buy
+11,000
New +$954K ﹤0.01% 4368

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Chase's WGS Position: Q1 2026 in Review

JP Morgan Chase increased its GeneDx Holdings (WGS) stake by 24% in Q1 2026, buying an estimated $595K and bringing the position to 33,674 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #4095.

JP Morgan Chase first reported a position in WGS in Q4 2020 and has held it in 19 quarters since. The position peaked at $8.29M in Q4 2024. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • JP Morgan Chase held 33,674 shares of GeneDx Holdings worth $2.01M as of Q1 2026.
  • JP Morgan Chase bought 6,526 GeneDx Holdings shares in Q1 2026, an estimated $595K.
  • GeneDx Holdings made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4095 holding.
  • JP Morgan Chase first reported a position in GeneDx Holdings in Q4 2020 and has held it in 19 quarters since.
  • JP Morgan Chase's GeneDx Holdings position peaked at $8.29M in Q4 2024.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.